Recently, a delegation from the Business department of Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.(hereinafter referred to as " NKF ")traveled all the way to Pakistan and was invited to attend the 25th anniversary celebration of the client GMS Company. They carried out brand promotion, strategic negotiation and product training for several days. This visit deepened the cooperation between the two sides and laid a solid foundation for future market expansion.
As the largest IVD (In Vitro Diagnostic) production and sales enterprise in Pakistan, GMS Company has deep government relations and a complete business network. At the 25th anniversary celebration, the team of NKF and GMS jointly reviewed the achievements of their cooperation and had in-depth discussions on the future strategic cooperation plan. Both sides agreed that consolidating the cooperative relationship and enhancing mutual trust are the keys to promoting common development.
During the strategic meeting, both sides focused on the bidding strategies for the products already on the market, the approval plans for the products that have been submitted for registration, and the registration roadmaps for potential products in the future. Through efficient communication, NKF and GMS have further clarified the collaborative path for product access and market promotion. It is expected that approximately 30 products will be approved for marketing in 2025 2026, providing local patients with more high-quality drug options.
To enhance the professional capabilities of the local sales team of GMS, the team of NKF conducted systematic training on tumor pipeline and anticoagulant vascular line products, and had in-depth exchanges in combination with the local market conditions. This training enhanced the local team's understanding of the advantages of our company's products and injected strong impetus into subsequent market promotion.
The team also made a special visit to a well-known local private hospital group, and through brand promotion, detailedly introduced our company's product layout and technical advantages in the fields of anticoagulation and oncology to the medical terminal. Face-to-face communication has further enhanced the recognition of our company's brand in the first-line medical circle of Pakistan.
This trip to Pakistan is not only an important step in NKF 's internationalization strategy, but also injects new vitality into the company's in-depth development in the South Asian market.
NKF will continue to fulfill its mission and responsibility of "driving the development of domestic pharmaceuticals with international quality, entering the international pharmaceutical market with international capabilities, and striving for the health of society and humanity". Through localized cooperation and professional promotion, it will provide more high-quality products to serve patients worldwide.
